Corman Victor M VM

Show results for

Genomics (2)
Metabolomics (1)

Organisms

Homo sapiens (2)

Repository

EGA (2)
MetaboLights (1)

Technology Type

Mass spectrometry (1)

Instrument Platform

Liquid Chromatography MS - negative - reverse phase (1)
Liquid Chromatography MS - positive - reverse phase (1)

Publication Date

2021 (1)

CHEBI ID

CHEBI:15422 (1)
CHEBI:15428 (1)
CHEBI:15603 (1)
CHEBI:15713 (1)
CHEBI:15721 (1)
CHEBI:15727 (1)
CHEBI:15729 (1)
CHEBI:15741 (1)
CHEBI:15746 (1)
CHEBI:15859 (1)
CHEBI:15891 (1)
CHEBI:15903 (1)
CHEBI:15971 (1)
CHEBI:15978 (1)
CHEBI:15996 (1)
CHEBI:16001 (1)
CHEBI:16015 (1)
CHEBI:16027 (1)
CHEBI:16264 (1)
CHEBI:16284 (1)
CHEBI:16311 (1)
CHEBI:16335 (1)
CHEBI:16349 (1)
CHEBI:16414 (1)
CHEBI:16467 (1)
CHEBI:16610 (1)
CHEBI:16643 (1)
CHEBI:16680 (1)
CHEBI:16695 (1)
CHEBI:16742 (1)

Metabolite Name

4-hydroxyproline (1)
5'-S-methyl-5'-thioadenosine (1)
L-alanine (1)
L-alpha-aminobutyric acid (1)
L-arginine (1)
L-asparagine (1)
L-aspartic acid (1)
L-citrulline (1)
L-cystathionine (1)
L-cysteine (1)
L-cysteinylglycine (1)
L-gamma-glutamyl-L-cysteine (1)
L-glutamic acid (1)
L-glutamine (1)
L-histidine (1)
L-homocysteine (1)
L-isoleucine (1)
L-leucine (1)
L-lysine (1)
L-methionine (1)
L-ornithine (1)
L-phenylalanine (1)
L-pipecolic acid (1)
L-proline (1)
L-serine (1)
L-threonine (1)
L-tyrosine (1)
L-valine (1)
N(1)-acetylspermidine (1)
N(1)-acetylspermine (1)

Previous page
1 / 1
You're on page 1
Next page

Sort by:

Relevance

Page size

SARS-CoV-2-mediated dysregulation of metabolism and autophagy uncovers host-targeting antivirals

Viruses manipulate cellular metabolism and macromolecule recycling processes like autophagy. Dysregulated metabolism might lead to excessive inflammatory and autoimmune responses as observed in severe and long COVID-19 patients. Here we show that SARS-CoV-2 modulates cellular metabolism and reduces ...

2021-06-11 | MTBLS2840 | MetaboLights

ena-DATASET-DKFZ-24-12-2020-10:12:59:494-197 - samples

In Coronavirus Disease 2019 (COVID-19), hypertension and cardiovascular diseases are major risk factors for critical disease progression. However, the underlying reasons and the effect of the main anti-hypertensive therapiesÃ¢Â€Â”angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin recep...

EGAD00001006828 | EGA

Hypertension delays viral clearance and exacerbates airway hyperinflammation in patients with COVID-19

In coronavirus disease 2019 (COVID-19), hypertension and cardiovascular diseases are major risk factors for critical disease progression. However, the underlying causes and the effects of the main anti-hypertensive therapies-angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin receptor b...

EGAS00001004772 | EGA